Duncan McKechnie, EVP, Chief Commercial Officer: Vertex Pharmaceuticals VRTX Planned sale · Filed 07/02

Trade details

Type: Planned sale notice
Stock: Vertex Pharmaceuticals VRTX
Person: Duncan McKechnieEVP, Chief Commercial Officer
Planned sale date: 26/07/02
Filed: 26/07/02

$799.8K to be sold

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 06/02~08/01

Duncan McKechnie's recent trades

Duncan McKechnieEVP, Chief Commercial Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.3M
2,633 sh
$1.3M
Filed 03/13
Traded 03/11
Duncan McKechnieEVP, Chief Commercial Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.3M
2,633 sh
$1.3M
Filed 03/11
Traded 03/11
Duncan McKechnieEVP, Chief Commercial Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.2M
2,437 sh
$1.2M
Filed 03/06
Traded 03/04
Duncan McKechnieEVP, Chief Commercial Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.2M
2,437 sh
$1.2M
Filed 03/04
Traded 03/04
Duncan McKechnieEVP, Chief Commercial Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.2M
2,500 sh
$1.2M
Filed 02/26
Traded 02/25